Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948155 · ClinicalTrials.gov registry record · Phase 4
Measuring Smoking Behaviors While Using Varenicline
A Phase 4 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 4
- Development phase
- 48
- Enrollment target
NCT00948155: Completed Phase 4 study, sponsored by University of Pennsylvania.
NCT00948155 is a Phase 4 study that has completed, run by University of Pennsylvania. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948155, a Phase 4 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 48 participants
- Enrollment target
Study Summary
This study will demonstrate the behavioral responses to varenicline, helping to better understand its mechanisms. Hypotheses for the study are to observe decreases in smoking topography and nicotine cigarette choice on varenicline, relative to placebo; and decreases on day 21 relative to day 7 during varenicline treatment. We also propose to examine if extended duration of treatment has clinical significance in decreasing smoking behaviors, thus increasing the efficacy of varenicline.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00948155
The ClinicalTrials.gov registry entry for NCT00948155 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT00948155 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00948155 about?
NCT00948155 is a clinical study titled "Measuring Smoking Behaviors While Using Varenicline". This study will demonstrate the behavioral responses to varenicline, helping to better understand its mechanisms. Hypotheses for the study are to observe decreases in smoking topography and nicotine cigarette choice on varenicline, relative to placebo; and decreases on day 21 relative to day 7 durin...
What is the current status of trial NCT00948155?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 48 participants. The study started on 2009-01. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00948155?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT00948155?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.